Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-07

FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s generic norepinephrine bitartrate injection (Original Application) as a vasopressor for treating life-threatening …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norepinephrine bitartrate (generic) (Norepinephrine bitartrate)

Snippet

ORIG AP for NOREPINEPHRINE BITARTRATE (NOREPINEPHRINE BITARTRATE)